Quantcast

Latest Autoimmunity Stories

2014-02-04 16:29:30

Lupus Research Organizations Welcome Big-Science Push to Drive New Therapies for Lupus Patients NEW YORK, Feb. 4, 2014 /PRNewswire/ -- The Alliance for Lupus Research (ALR) and the Lupus Research Institute (LRI) are proud to join the National Institutes of Health (NIH) in the Accelerating Medicines Partnership (AMP) launched today to speed new paths to treatment for lupus and autoimmune diseases. The new $230 million collaboration will harness the collective knowledge and resources...

2014-02-04 12:27:31

Lupus Foundation of America Joins a Five-Year Initiative to Bring Together Government, Academia, Industry and Nonprofit Health Organizations to Harness Capabilities and Resources WASHINGTON, Feb. 4, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America will partner with the Foundation for the National Institutes of Health (FNIH) to support a new five-year initiative that will accelerate the ability to develop new medicines for lupus and other diverse and complex diseases....

2014-01-30 16:26:47

HAYWARD, Calif., Jan. 30, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, announced today that Paul F. Truex, President and Chief Executive Officer, will present a corporate update on the progress of the Company's development programs including additional plans for blisibimod beyond autoimmune disorders at three conferences in February and early March. Investor...

2014-01-14 16:25:08

Brings Total to $6.6 Million to Educate Healthcare Professionals on Front-Lines of Care NEW YORK, Jan. 14, 2014 /PRNewswire/ -- The 2014 Omnibus Appropriations Bill released by the U.S. Congress last night provides $2 million to further the Lupus Initiative, the lupus provider education program conceived by the Lupus Research Institute (LRI) in collaboration with the federal government. Expected to pass this week, the appropriation will bring total support to $6.6 million for the...

2014-01-13 12:27:53

SEATTLE, Jan. 13, 2014 /PRNewswire/ -- Adaptive Biotechnologies announced today a biomarker discovery agreement facilitated by the Johnson & Johnson Innovation Center in California. Under the agreement, Adaptive will use its patented immune profiling assay, immunoSEQ(TM), to enable an in-depth characterization of the immune response to diseases being studied and select immunology and oncology drugs being developed by Janssen Research & Development, LLC (Janssen). The...

2014-01-08 08:28:48

PORTLAND, Ore., Jan. 8, 2014 /PRNewswire-USNewswire/ -- To advance understanding of psoriasis--the most common autoimmune disease in the country, affecting up to 7.5 million Americans--and help scientists and clinicians improve treatments and patient outcomes, the National Psoriasis Foundation (NPF) and the Consortium of Rheumatology Researchers of North America, Inc. (CORRONA) will create the first psoriasis registry co-developed and co-administered by a nonprofit. (Photo:...

2014-01-07 23:01:17

A 2.5-Day Summit Providing Groundbreaking Approaches to Treating Patients With Interrelated Autoimmune Conditions Malvern, PA (PRWEB) January 07, 2014 The Interdisciplinary Autoimmune Summit (IAS) is pleased to announce the Keynote Address to be presented by Noel R. Rose, MD, PhD, Professor of Pathology, Professor of Molecular Microbiology and Immunology, Director, Johns Hopkins Center for Autoimmune Disease Research, The Johns Hopkins Medical Institutions. On Friday, June 20, 2014 at...

2014-01-06 08:25:03

EDGEWATER, N.J., Jan. 6, 2014 /PRNewswire/ -- DiaVacs, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted orphan drug designation for the company's type 1 diabetes mellitus (T1DM) therapy. DV-0100 is proprietary, novel and safe. The therapy halt's the body's autoimmune reaction against the pancreatic islet cells which are responsible for producing insulin, thus allowing them to produce insulin normally and...

2013-12-31 16:22:09

What is Lupus? WASHINGTON, Dec. 31, 2013 /PRNewswire-USNewswire/ -- There have been many reports and rumors in the media and on the internet, asking questions about the autoimmune disease lupus and who might be suffering from this devastating disease. (Photo: http://photos.prnewswire.com/prnh/20131231/DC39345-INFO) (Logo: http://photos.prnewswire.com/prnh/20121113/DC11393LOGO) The real question is: what is lupus? What are the debilitating effects of living with the disease? When...

2013-12-19 10:35:03

A newly identified immune protein influences each person's response to vaccines and risk for autoimmune diseases like lupus and multiple sclerosis, according to a study published today by researchers from the School of Medicine at the University of Alabama at Birmingham in the journal Science Translational Medicine. The protein, called a receptor and part of signaling pathways, also provides a new target for personalized therapies for patients with autoimmune diseases. The research team...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.